Intarcia Therapeutics is a biopharmaceutical company developing therapies for chronic diseases. Its flagship product, Medici Drug Delivery System, aims to transform the prevention and management of chronic diseases. The products of the company include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady-state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity.